Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in Type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning
- 1 January 1990
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 33 (1) , 52-59
- https://doi.org/10.1007/bf00586461
Abstract
The aim of the present studies was to test the hypothesis that the dawn phenomenon in Type 1 (insulin-de-pendent) diabetes mellitus is due to a decrease in insulin sensitivity caused by nocturnal spikes of growth hormone. Twelve subjects with Type 1 diabetes were studied on two different occasions, from 24.00 to 02.00 hours, and from 06.00 to 08.00 hours with the euglycaemic clamp technique at two plasma free insulin levels (≈25 mU/l,n=7; ≈80 mU/l,n=5). To eliminate the confounding factor of insulin waning of previous Biostator studies, prior to clamp experiments the diabetic subjects were infused with i.v. insulin by means of a syringe pump according to their minute-to-minute insulin requirements. Insulin sensitivity decreased at dawn as compared to the early night hours (≈30% increase in the rate of hepatic glucose production, ≈25% decrease in the rate of peripheral glucose utilisation). Plasma insulin clearance did not change overnight. In seven Type 1 diabetic subjects, suppression of nocturnal spikes of growth hormone secretion by somatostatin during basal glucagon and growth hormone replacement resulted in complete abolition of the increased rate of hepatic glucose production at dawn. Replacement of nocturnal spikes of growth hormone faithfully reproduced the increase in hepatic glucose production at dawn of the control study. It is concluded that the dawn phenomenon in Type 1 diabetes mellitus examined during optimal insulin replacement, first, is due solely to a decrease in insulin sensitivity and not to an increase in insulin clearance; second, that the decrease in insulin sensitivity at dawn takes place both in the liver and peripheral tissues; third, that the decrease in hepatic (and most likely extrahepatic) insulin sensitivity at dawn is caused by nocturnal spikes of growth hormone secretion.Keywords
This publication has 49 references indexed in Scilit:
- The Effect of Asymptomatic Nocturnal Hypoglycemia on Glycemic Control in Diabetes MellitusNew England Journal of Medicine, 1988
- Alterations in Insulin Clearance and Hepatic Blood Flow during the Night Do Not Contribute to the ‘Dawn Phenomenon’ in Type 1 DiabetesHormone Research, 1988
- Pathogenesis of the Dawn Phenomenon in Patients with Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1985
- Abnormal Glucose Counterregulation after Subcutaneous Insulin in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.BMJ, 1983
- Control of Blood Sugar in Insulin-Dependent Diabetes: Comparison of an Artificial Endocrine Pancreas, Continuous Subcutaneous Insulin Infusion, and Intensified Conventional Insulin TherapyNew England Journal of Medicine, 1980
- Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose CounterregulationJournal of Clinical Investigation, 1979
- Regulation of brittle diabetics by a pre-planned insulin infusion programmeDiabetologia, 1976
- THE EFFECT OF FASTING AND GLUCOSE LOAD ON INSULIN SECRETION AND THE STAUB—TRAUGOTT PHENOMENON IN PIGSJournal of Endocrinology, 1973